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Abstract: Single-cell sequencing technologies, i.e., single cell analysis followed by deep sequencing
investigate cellular heterogeneity in many biological settings. It was only in the past year that
single-cell sequencing analyses has been applied in the field of virology, providing new ways to
explore viral diversity and cell response to viral infection, which are summarized in the present review.
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1. Introduction
Cell population analysis is an essential tool to investigate cellular biology and response to
infection. However, cell populations consist of a mixture of cells that may differ in their identity
(cell type/subpopulation/lineage), in their state/process (cell cycle, circadian rhythm), or just due to
stochastic variation. Rare cells and subsets, potentially relevant for some specific phenotypes, might
be missed by cell population analyses. The steps to address cell heterogeneity include: (i) single
cell separation and isolation (such as micromanipulation, fluorescence-activated cell sorting (FACS),
microdroplets, microfluidics); and (ii) sensitive analysis that can accommodate and process the limited
amount of biological material (deep sequencing (DNA-Seq, ATAC-Seq, RNA-Seq), FACS, single cell
mass cytometry (CyTOF), time-lapse microscopy) (recently reviewed in [1–3]). Single-cell sequencing
studies performed at the genome-wide or transcriptome-wide levels have already proven useful for
many application fields, including cancer, immunology, embryology, and microbiology [1].
Heterogeneity in cell population occurs in cells thought to share an identical DNA. However,
there is increasing interest in characterizing the levels of somatic variation at DNA level. Indeed, cells
within one organism all derived initially from the same zygote cell, thus, from one single source of
genomic information. However, with subsequent divisions and under different microenvironmental
influences, cells accumulate genomic (somatic) mutations. An example to illustrate the importance of
somatic heterogeneity is cancer. Here, analysis may reveal the existence of rare transformed individual
cells, differences in driver mutations, and diverse resistance mechanisms in response to treatment [4–9].
There is also a great interest in the identification of somatic structural variations in normal tissues—in
particular, in the brain [10].
Transcriptome analysis of single cells is now broadly used as well—and significant information in
this review will refer to this. The observation of single cell heterogeneity in response to viral infection
is well established, and already the focus of sophisticated approaches [11]. Publications on single cell
studies followed by deep sequencing only took off about one year ago. The aim of this review is to
provide an overview of single cell studies (summarized in Table 1) while focusing more on single-cell
sequencing studies published to date in the field of virology, aiming at exploring viral diversity as well
as individual cell variability in response to viral replication.
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2. The Origins of Single Cell Heterogeneity at the Transcriptome Level
As mentioned above, cell-to-cell transcription variability depends on the cell identity itself at first.
The pool of T cells is a great example of such heterogeneity as it is composed of many different cell
subtypes and subsets [6,9,12–15]. Additional layers of variability have been shown to originate in the
cell population context, i.e., the local cell density and the cell position in the population [11], in the cell
cycle [16], and in the transcription stochasticity. Recently, it has been shown that noise due to stochastic
variation of transcription was quite low when considering cytoplasmic transcripts [17–19]. Indeed,
cell-to-cell variation at the transcriptional level was present in the nucleus but not in the cytoplasm,
suggesting that transcripts were retained in the nucleus, thereby buffering transcript variation in the
cytoplasm. The mechanisms involved in nuclear retention of transcripts remain to be elucidated but
may involve epitranscriptomic regulation, i.e., chemical modifications of RNA molecules such as m6A
methylation [20]. The presence of nuclear transcript retention may also provide an explanation for
the low correlation between transcript levels and protein levels, in contrast to ribosome-associated
transcript levels and protein levels. Therefore, it would be interesting to determine the level of
correlation between cytoplasmic transcripts and proteins.
Cellular heterogeneity will, thus, affect virus replication from the initial infection of the cell to
viral release, and thus also affect the clinical outcome of the viral infection. The impact of cell-to-cell
variation on the viral life cycle can be investigated from the point of view of the virus, i.e., by analyzing
viral sequences, or from the point of view of the cell, i.e., by analyzing the cellular transcriptome.
3. Virus-Based Analyses
3.1. The Impact of Cellular Heterogeneity on Viral Replication (Expression and Yield)
As mentioned above, single cell analysis has to deal with single cell isolation and processing
of limited amount of sample. Single cell isolation was easier to overcome than subsequent analysis.
Thus, initial studies mostly investigated one viral-encoded fluorescent reporter gene over time in
single cells by FACS or by time-lapse microscopy [21,22] (Table 1). These studies led to the first
appreciations of cell-to-cell variability in human immunodeficiency virus (HIV) gene expression and
helped determining that infected cells usually contained one integrated HIV copy (Figure 1).
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Figure 1. Single cells display cell-to-cell variability in gene expression. Graph plot showing the
expression of a virus-encoded fluorescent reporter over time post-infection as quantified by time-lapse
microscopy. (Adapted from [21]).
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Although delayed as being technically more challenging, single-cell proteomics is also moving
forward for single cell phenotyping, growing from the simultaneous detection of up to 18 proteins
by FACS to more than 40 proteins by CyTOF, and providing a valuable tool to start characterizing
variation of cellular protein expression at the single cell level [23,24]. A large majority of single cell
studies investigated cellular heterogeneity at the level of viral gene expression and infectious virion
progeny production using specific reverse transcription polymerase chain reaction (RT-PCR) and
plaque assays (Table 1).
Table 1. Single cell analysis studies.
Virus a Cells b Single Cell Isolation
Biological Sample
Analyzed c Method Reference
SV40
(RV, MHV,
DENV)
HeLa - Immunofluorescence Microscopy andimaging Snijder et al. [11]
DENV
B cells from DENV
seropositive
patients
FACS sorting Cellular RNA Deep-sequencing Cox et al. [25]
FMDV BHK-21 Micromanipulation vRNA RT-PCR Huang et al. [26]
HBV Primaryhepatocytes Microscopy
vRNA, vDNA,
cccDNA
In Situ
Hybridization Zhang et al. [27]
HCV Huh-7.5 (hepatomacell line) FACS
Virus-encoded BFP
and RFP reporters FACS Luna et al. [28]
HCV Huh-7 (hepatomacell line) Micromanipulation vRNA
Deep-sequencing,
RT-qPCR
McWilliam
Leitch and
McLauchlan [29]
HIV Jurkat (human Tcell line) Micromanipulation Virus-encoded GFP
Time-lapse
microscopy, FACS
Weinberger et al.
[22]
HIV
Primary human
CD4+ T cells (from
blood)
Micromanipulation Virus-encoded GFP Time-lapsemicroscopy
Razooky et al.
[21]
HIV
Primary human
CD4+ T cells (from
infected patients)
Microdissection vDNA PCR-Sequencing Suspène andMeyerhans [30]
HIV
Primary human
CD4+ T cells (from
infected patients)
FACS sorting vDNA, vRNA Deep-sequencing Josefsson et al.[31]
HIV Primary humanCD4+ T cells
Microfluidics
(Fluidigm) RNA Deep-sequencing
Ciuffi et al.
[32,33]
HPV HeLaS3 MIRALCS pipeline Cellular RNA andvRNA RNA-Seq Wu et al. [34]
HTLV
Cytotoxic T
lymphocytes from
Adult-T-Leukemia
(ATL) patients
FACS sorting Cellular RNA (T-CellReceptor repertoire) Deep-sequencing Tanaka et al. [35]
IAV MDCK Micromanipulation vRNA, virionprogeny
RT-qPCR, plaque
assay
Heldt et al. [36];
Laske et al. [37]
Poliovirus HeLaS3 FACS sorting Virion progeny,vRNA
Plaque assay,
RT-qPCR
Schulte and
Andino [38];
Schulte et al. [39]
VSV BHK-21 FACS sorting Virion progeny Plaque assay Zhu et al. [40]
VSV BHK-21 Micromanipulation Virion progeny Plaque assay Timm and Yin[41]
VSV BHK-21 Micromanipulation
Virion progeny
(Virion-associated
vRNA)
Deep-sequencing Timm et al. [42]
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Table 1. Cont.
Virus a Cells b Single Cell Isolation
Biological Sample
Analyzed c Method Reference
VSV BHK-21 Micromanipulation Virus-encoded GFP,virion progeny
Time-lapse
microscopy, plaque
assay
Akpinar et al.
[43]
VSV BHK-21 Micromanipulation
Virion progeny
(Virion-associated
vRNA)
Deep-sequencing,
plaque assay Combe et al. [44]
VZV Primary human Tcells (from tonsils)
Mass Cytometry
(CyTOF)
Set of 40 protein
markers
Mass Cytometry
(CyTOF) Sen et al. [23,45]
WNV
Primary B cells
(from infected
patients)
Microengraving
pipeline
Cellular RNA,
Antibodies
Deep-sequencing,
neutralization
assay
Tsioris et al. [46]
a DENV Dengue Virus; FMDV Foot-and-Mouth Disease virus; HBV Hepatitis B Virus; HCV Hepatitis C Virus;
HIV Human Immunodeficiency Virus type 1; HPV Human Papilloma Virus; HTLV Human T-cell Leukemia
virus; IAV Influenza A Virus; MHV Mouse Hepatitis Virus; RV Rotavirus; SV40 Simian Virus 40; VSV Vesicular
Stomatitis Virus; VZV Varicella Zoster Virus; WNV West Nile Virus; b BHK-21 Baby Hamster Kidney; MDCK
Madine-Darby Canine Kidney; c GFP green fluorescent protein; vRNA viral RNA (intracellular); cccDNA
covalently closed circular DNA.
3.1.1. Vesicular Stomatitis Virus (VSV)
VSV, containing a non-segmented, single-stranded RNA genome of negative polarity, was used as
a first model to explore cellular heterogeneity at the level of production of infectious particles (Figure 2).
Initial studies showed that 24 h post-infection at a multiplicity of infection (MOI) of 5, the virus yield
of infectious particle progeny was affected by cell cycle, with G2M phase associated with a higher
number of plaque forming units (PFU) than the S phase. More importantly, the yield ranged from 50 to
8000 PFU per single cell [40]. This cell-to-cell variability in virion progeny production was investigated
for many other viruses (as listed in Table 1). A few of these studies are detailed below.
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Figure 2. Single cells display cell-to-cell varia ilit i i f ctious viral progeny. Cells are infected t a
determined multiplicity of infection, usually represented by a virus aggregate containing infectious
(colored) and defective particles (empty, defective interfering particles, DIP). The genomic sequence of
infectious, competent viruses may vary among viral particles, represented here by a yellow and a red
particle. After infection, cells are separated and grown for 24 h. Cells are then collected for assessing
specific gene expression (usually viral RNA) by RT-qPCR, while supernatants are collected to perform
plaque assay for infectious titer determination.
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Akpninar et al. analyzed the impact of defective interfering particles (DIP) aggregated to infectious
particles for overall infection success [43]. For this, BHK-21 cells were co-infected for 24 h with a
fixed MOI (MOI = 30) of VSV competent particles and variable amounts of VSV-DIP. The success of
infection was followed by titration of infectious virion progeny (plaque assay) or by detection of a
virally-encoded fluorescent reporter (time-lapse microscopy) (Figure 2). The number of infectious
particles (PFU) produced by infected cells was reduced when higher amounts of DIP were used
during initial co-infection. Similarly, the expression level of the virus-encoded fluorescent reporter was
also reduced with high amounts of DIP. All together, these data suggest that VSV-DIP interfere with
successful and productive infection of replication-competent VSV, probably due to particle competition
for intracellular resources necessary for viral genome replication, expression, and production. This
system also allowed following viral gene expression over time within the same cell, thereby informing
on cell-to-cell variability, as well as the kinetics of viral protein synthesis and expression. Finally, cell
density may also impact single cell behavior as an isolated single cell might behave differentially than
an individual cell in context of a population. Indeed, DIP interfere more with isolated single cells
compared to single cells in a dense population, as assessed by viral reporter expression and virus yield.
Combe et al. analyzed cellular heterogeneity in the outcome of VSV infection [44]. For this
purpose, they infected Baby Hamster Kidney (BHK)-21 cells with VSV particles that were previously
sequenced to know the input viral genomic diversity, identifying 197 single-nucleotide polymorphisms
(SNP, parental variants). Infected cells were then separated by micromanipulation and incubated for
24 h, thereby allowing two rounds of virus generation. Supernatants were used to quantify infectious
virion progeny by plaque assay, followed by deep sequencing to explore genetic diversity. Results,
derived from a total of 90 infected cells and 881 plaques (7–10 plaques per infected cell), first identified
a total of 532 SNP, 36 originated in the viral stock and 496 newly arising SNP, corresponding to a
mutation rate of 2.8 ˆ 10´5 mutations per nucleotide per cell infection (or on average 5.51 new SNP
identified in 7–10 plaques), and allowing a rapid gain of genetic diversity. A second observation relied
in the presence of multiple parental variants in many infected cells consistent with virus co-infection.
Indeed, data were consistent with the hypothesis that one infectious unit was composed of an aggregate
of virions, in which at least one was infectious and replication competent while the others were mostly
defective (DIP). This observation suggests that cells are mostly co-infected by multiple viral variants,
enabling a rapid generation of genetic diversity in the virion progeny.
3.1.2. Hepatitis C Virus (HCV)
McWilliam, Leitch, and McLauchlan investigated HCV, a positive single-stranded RNA virus.
In particular, they analyzed the viral diversity of HCV replicon quasi-species by RT-qPCR and vRNA
deep-sequencing in individual cells [29]. They determined that on average, one single cell contained
113 copies of replicon RNA (ranging from 84 to 160 copies). Furthermore, analysis of viral variants
highlighted a large dominance of wild type (wt) sequence, although minor variants were also identified.
3.1.3. Hepatitis B Virus (HBV)
Zhang et al. investigated HBV infection and quantified at single cell level the amount of
intracellular viral nucleic acids, which are cytoplasmic vRNA and vDNA, as well as nuclear
covalently-closed circular DNAs (cccDNA) [27]. In situ hybridization assay on liver biopsies of
chronic hepatitis B infection was able to detect HBV cccDNA in patients’ cells, even after one year
of patient treatment, suggesting the high-level resistance and persistence of this viral genomic form.
Furthermore, this latent stage of infection also co-occurred with the absence of detection of the HBV
surface antigen (HBsAg). All together, these data highlighted a specific temporal pattern of HBsAg
expression, virion production, or cccDNA detection, which co-occur with productive or latent phase of
HBV life cycle.
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3.1.4. Influenza A Virus (IAV)
Heldt et al. investigated cell-to-cell variability in IAV infection, which contains eight negative
single-stranded genomic segments [36]. For this, they infected MDCK cells, isolated the infected
cells by serial dilution and analyzed intracellular viral RNA (vRNA) of single cells by RT-qPCR as
well as virion progeny by plaque assay 12 h post-infection. Key findings of this study revealed high
cellular heterogeneity due to both intrinsic and extrinsic noise origins, i.e., stochastic variation and
use of cellular resources (biochemical reactions necessary for intracellular viral life cycle progression),
respectively. Indeed, they first showed variability in vRNA expression levels between infected cells
as well as differences in the copy number of the various vRNA segments within the same infected
cell. These vRNA expression differences eventually led to up to 3-log differences in release of virion
progeny, with single cells releasing from 1 to 970 PFU. Furthermore, many infected cells were unable to
release viral particles, either due to the presence of defective interfering particles (DIP), due to failure
to achieve endosomal fusion, or due to vRNA degradation (genomic segment loss).
4. Cell-Based Analyses
4.1. The Impact of Cellular Heterogeneity on Virus-Induced Cellular Immune Response
Tsioris et al. investigated the humoral immune response of West Nile Virus (WNV)-infected patient
cells [46]. The authors collected blood samples from infected patients with recent or post-convalescent
WNV infections, isolated B cell subpopulations and processed them using a single cell analysis
approach (microengraving) aiming at capturing, sequencing, and characterizing WNV-specific
antibodies. At the same time, analysis of the B cell repertoire (i.e., heavy chain sequences) was carried
out. Data revealed that WNV-specific cells persisted over time, during patients’ post-convalescence and
that the humoral response was not predictive of the WNV infection severity. The authors also identified
four novel WNV neutralizing antibodies (NAb). A similar analysis on the humoral immune response
for Dengue Virus (DENV) was carried out by Cox et al. using a FACS-based approach to capture
DENV-specific memory B cells, followed by differentiation and secreted antibody characterization on
one hand and by single cell sequencing of antibody sequence on the other hand [25]. This method
allowed for quantification of Dengue-specific memory B cells and Ab functional characterization.
4.2. The Impact of Viral Infection on Cellular Transcriptome
Luna et al. investigated HCV and the role of miR-122 binding to the viral RNA genome in favoring
HCV replication in hepatoma cells [28]. The use of single cell analysis by FACS of two bidirectional
fluorescent reporters was carried out to confirm a “sponge” effect of miR-122. Indeed, in absence
of HCV, miR-122 binds to cellular mRNA targets, thereby promoting their degradation and, thus,
reducing related encoded proteins. In presence of HCV, that binds and thus sequesters miR-122,
the free pool of miR-122 is reduced, thereby leading to a de-repression of miR-122 target cellular
mRNAs and to an increase of the corresponding encoded proteins. To summarize, miR-122 acts as a
translational regulator of a specific subset of cellular mRNAs and can be blocked by HCV.
4.3. The Impact of Cellular Heterogeneity on Viral Infection Outcome
Wu et al. investigated the cellular heterogeneity of virally-induced tumors [34]. To achieve
this, they analyzed in detail the whole transcriptome of HeLa S3 cells, a HPV18-infected cell line
derived from a cervical cancer. They developed an automated pipeline, named micro-well full-length
mRNA amplification and library construction system (MIRALCS), to isolate >500 single cells, perform
the reverse transcription, amplify the cDNA, and prepare the library for deep-sequencing (single
ends/50 nucleotides for 37 individual cells and paired-ends/150 nucleotides for eight individual
cells). They observed a cell-to-cell variation in the number of total transcripts detected, ranging from
67,000 to 233,000 transcript copies per cell. Cellular heterogeneity was also highlighted at the level
of splicing variation, including virus-host fusion transcripts. Finally, expression of viral E6 and E7
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oncogenes was co-incident with a cluster of 281 cellular genes, potentially involved in virus-mediated
cellular transformation.
Ciuffi et al. investigated cell heterogeneity by studying the differential permissiveness of primary
CD4+ T cells to HIV infection [33]. The authors established a single cell RNA-Seq approach with a
dedicated bioinformatic pipeline to identify biomarkers of HIV permissiveness [47]. More than 80 cells
from each cell donor, i.e., displaying the high permissive or low permissive phenotype, were analyzed
using a microfluidics to isolate single cells and RNA-Seq. Transcripts displaying a differential and
bimodal expression were considered as candidate biomarkers and were further tested.
Similarly, Martin-Gayo et al. studied cell heterogeneity of a subset of dendritic cells (DCs) from
Elite Controller patients (EC) previously described to have a more efficient immune response against
HIV-1 infection [48,49]. The authors single-cell sorted DCs (85 cells) that were previously challenged
with HIV-1 and performed a whole transcriptome analysis. Single-cell RNA-Seq revealed three different
transcriptional patterns that differed mainly on the expression of interferon stimulated genes (ISGs),
cytokines, cytokine receptors, and co-stimulatory molecules. Focusing on one of the transcription
profiles, the authors were able to identify specific markers that characterize a highly-functional subset
of DCs with improved abilities to induce T cell proliferation.
5. Discussion
The single cell technology has proven to be a valuable tool to explore DNA, RNA, or proteins in
one single cell at a time. To achieve that goal, this technology had to deal with ways to isolate and
capture cells, and to accommodate limited amounts of biological material. Although most studies
currently focus on one type of omic data only (DNA, RNA, epigenome), the technology is still evolving,
already allowing gathering multiple omic data (e.g., DNA and RNA) from one same single cell [50].
Finally, recent effort is being devoted to increase the throughput of single cell analysis in order to collect
data from a higher number of individual cells. Thus, single cell analyses allows for re-examination
of key viral features of replication in the context of simple models, as represented by a single cell
(Figure 3a,b). Investigating the impact of virus replication on specific cell subsets or specific cell
states should help reconstitute the viral phenotype observed at the cell population (Figure 3c). Single
cell transcriptome analysis and single cell proteomics should help identify a cell-specific signature,
informing on both cell lineage and cell state in an unbiased way.
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Figure 3. Single cell analysis and impact of cell-to-cell variability on virus replication. (a) Cell
population may contain multiple cell subsets, displaying high (red) and low (green) susceptibility to
viral replication; (b) cell population may contain cells in different states (differentiation, cell cycle),
affecting their susceptibility to viral infection. For example, cells in the S phase might display high
levels of susceptibility to viral infection (red) while cells in G0 a low susceptibility to infection (green);
and (c) complexity of cell population when cellular heterogeneity is a mixture of cells of multiple
subsets, in multiple states, and in different proportions.
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